KF31327
|
|
|
- CAS号:
- 220060-39-9
- 英文名:
- KF31327
- 英文别名:
- KF31327;Thioquinapiperfil;KF-31327 free base;Thioquinapiperifil;3-ethyl-8-[[2-[4-(hydroxymethyl)piperidin-1-yl]phenyl]methylamino]-1H-imidazo[4,5-g]quinazoline-2-thione;2H-Imidazo[4,5-g]quinazoline-2-thione, 3-ethyl-1,3-dihydro-8-[[[2-[4-(hydroxymethyl)-1-piperidinyl]phenyl]methyl]amino]-
- 中文名:
- KF31327
- 中文别名:
- 硫喹哌非;西地那非杂质35;化合物 T26273
- CBNumber:
- CB02104148
- 分子式:
- C24H28N6OS
- 分子量:
- 448.58
- MOL File:
- 220060-39-9.mol
|
|
|
KF31327性质、用途与生产工艺
Thioquinapiperifil (KF31327 free base) 是有效的、选择性的、非竞争性的磷酸二酯酶 (PDE-5) (IC50 为 0.074 nM) 的抑制剂，可用于性成熟的研究。
|
PDE5
0.074 nM (IC
50
)
|
PDE1
380 nM (IC
50
)
|
PDE2
670 nM (IC
50
)
|
PDE3
38 nM (IC
50
)
|
PDE4
800 nM (IC
50
)
|
Thioquinapiperifil can be found in dietary supplements.
Thioquinapiperifil (KF31327 free base) (0.1-10 μM) concentration dependently inhibits platelet aggregation. In the absence of nitroglycerin, higher concentrations 1 and 10 μM of Thioquinapiperifil (KF31327 free base) are required to inhibit platelet aggregation.
Thioquinapiperifil (KF31327 free base) and shows significant increase in cyclic GMP at 10 μM. After 5 min incubation, the mean cyclic GMP levels of Thioquinapiperifil (KF31327)-treated cells is 0.95±0.17 pmol/10
8
cells.
KF31327
上下游产品信息
上游原料
下游产品
220060-39-9, KF31327 相关搜索:
- 标准品
- C24H28N6OS
- 硫喹哌非
- 化合物 T26273
- 西地那非杂质35
- 220060-39-9
- Thioquinapiperfil
- KF-31327 free base
- 2H-Imidazo[4,5-g]quinazoline-2-thione, 3-ethyl-1,3-dihydro-8-[[[2-[4-(hydroxymethyl)-1-piperidinyl]phenyl]methyl]amino]-
- Thioquinapiperifil
- 3-ethyl-8-[[2-[4-(hydroxymethyl)piperidin-1-yl]phenyl]methylamino]-1H-imidazo[4,5-g]quinazoline-2-thione
- KF31327